Gyre Therapeutics Inc (GYRE)

Dec 20, 2024

Gyre therapeutics president Ma Songjiang sells $44,851 in stock By Investing.com - Investing.com Australia

Dec 20, 2024

Dec 19, 2024

Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat

Dec 19, 2024

Dec 19, 2024

Gyre therapeutics president Ma Songjiang sells $44,851 in stock - Investing.com

Dec 19, 2024

Dec 17, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Up 9.1%Time to Buy? - MarketBeat

Dec 17, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Has $1.43 Million Stock Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - MarketBeat

Dec 17, 2024

Dec 16, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpHere's What Happened - MarketBeat

Dec 16, 2024

Dec 14, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Increase in Short Interest - MarketBeat

Dec 14, 2024

Dec 14, 2024

Gyre Therapeutics (NASDAQ:GYRE) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Dec 14, 2024

Dec 05, 2024

Contrasting Gyre Therapeutics (NASDAQ:GYRE) and Bioxytran (OTCMKTS:BIXT) - Defense World

Dec 05, 2024

Nov 16, 2024

Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Declines By 16.1% - MarketBeat

Nov 16, 2024

Nov 15, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 7.8%Here's Why - MarketBeat

Nov 15, 2024

Nov 15, 2024

Gyre Therapeutics Third Quarter 2024 Earnings: EPS: US$0.013 (vs US$0.68 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates - TipRanks

Nov 14, 2024

Nov 13, 2024

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - The Manila Times

Nov 13, 2024

Nov 13, 2024

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides - The Bakersfield Californian

Nov 13, 2024

Nov 13, 2024

Gyre Therapeutics Revenue Falls 20% as Phase 3 Trial Milestone Nears Critical Data | GYRE Stock News - StockTitan

Nov 13, 2024

Oct 23, 2024

VirTra Appoints Retired U.S. Army Lieutenant General Maria R. Gervais and Georgia POST Executive Director Mike Ayers to Board of Directors - The Manila Times

Oct 23, 2024

Oct 22, 2024

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times

Oct 22, 2024

Oct 22, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat

Oct 22, 2024

Oct 14, 2024

AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World

Oct 14, 2024

Oct 04, 2024

Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) market cap dropped US$51m last week; Public companies bore the brunt - Yahoo Finance

Oct 04, 2024

Oct 03, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World

Oct 03, 2024

Oct 03, 2024

Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World

Oct 03, 2024

Oct 03, 2024

Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World

Oct 03, 2024

Oct 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat

Oct 03, 2024

Oct 02, 2024

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times

Oct 02, 2024

Sep 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat

Sep 18, 2024

Sep 18, 2024

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga

Sep 18, 2024

Sep 17, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat

Sep 17, 2024

Sep 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat

Sep 06, 2024

Sep 05, 2024

Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com

Sep 05, 2024

Sep 04, 2024

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024

Sep 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat

Sep 03, 2024

Sep 02, 2024

Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Grows By 5.4% - MarketBeat

Sep 02, 2024

Aug 28, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 4.1% Higher - MarketBeat

Aug 28, 2024

Aug 27, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 6.6% - MarketBeat

Aug 27, 2024

Aug 26, 2024

Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading Volume - MarketBeat

Aug 26, 2024

Aug 25, 2024

Bicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary - Benzinga

Aug 25, 2024

Aug 19, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Growth in Short Interest - MarketBeat

Aug 19, 2024

Aug 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.2% - MarketBeat

Aug 19, 2024

Aug 19, 2024

Vanguard Group Inc. Reduces Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

Aug 19, 2024

Aug 15, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40 - MarketBeat

Aug 15, 2024

Aug 13, 2024

GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024

Aug 13, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.9% - MarketBeat

Aug 13, 2024

Aug 13, 2024

Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - BioSpace

Aug 13, 2024

Aug 13, 2024

Sidoti Events, LLC's Virtual August Micro-Cap Conference - AccessWire

Aug 13, 2024

Aug 12, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 6.7% Higher - MarketBeat

Aug 12, 2024

Aug 09, 2024

Gyre Therapeutics to Present at Sidoti Virtual Investor Conference - ForexTV.com

Aug 09, 2024

Aug 08, 2024

Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team - TipRanks

Aug 08, 2024

Aug 08, 2024

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - StockTitan

Aug 08, 2024